TTR and gastric cancer: Shen et al investigated the prognostic significance of pretreatment prealbumin in 731 stage II/III GC patients with the cutoff value of 180 mg/l.[24] They found low prealbumin level was an independent risk factor of overall survival (HR: 1.362, 95% CI, 1.094–1.695, P = .006) and disease-free survival (HR: 1.369, 95% CI, 1.099–1.706, P = .005).